Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors
接受至少三个月免疫检查点抑制剂治疗的患者骨转移的演变
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-022-03180-x
Gefard-Gontier, E; Markich, R; Zysman, M; Veillon, R; Daste, A; Domblides, C; Sionneau, B; Gross-Goupil, M; Lefort, F; Prey, S; Dutriaux, C; Gerard, E; Dousset, L; Pham-Ledard, A; Beylot-Barry, M; Schaeverbeke, T; Kostine, M